Docket Room.
SB 392·MD·senate

Maryland Technology Development Corporation - Long COVID Innovation Grant and Loan Program

FailedFiled Jan 28, 2026
Sponsor: King
Latest Action

Hearing (Senate)

Feb 12, 2026

Email me when SB 392 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SB 392. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill would have the Maryland Technology Development Corporation set up a fund and a grant‑loan program to support state‑based research, product development, and manufacturing aimed at treating Long COVID. An independent scientific review committee would evaluate proposals, and the corporation would award and oversee the money. The measure failed to pass.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SB 392

3 free questions a day, no account

Hearings

History

  1. Hearing 2/12 at 1:00 p.m.
  2. First Reading Finance

Sponsors

  • King · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SB 392 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SB 392 free

Or ask your AI assistant about SB 392 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice